Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Shozo Koshikawa"'
Autor:
Makoto, Hiramatsu, Minoru, Kubota, Manabu, Iwasaki, Tadao, Akizawa, Shozo, Koshikawa, Yoshihiro, Tsujimoto
Publikováno v:
Therapeutic Apheresis and Dialysis. 12:19-27
Darbepoetin alfa (KRN321) is a novel molecule that stimulates erythropoiesis by the same mechanism as endogenous erythropoietin. Due to its longer half-life and greater biological activity than recombinant human erythropoietin (rHuEPO), KRN321 mainta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbd4b00376f9dbc2dbb7f085ea8c7be4
https://doi.org/10.1111/j.1744-9987.2007.00525.x
https://doi.org/10.1111/j.1744-9987.2007.00525.x
Autor:
Tadao Akizawa, Fumie Saji, Eriko Kinugasa, Fumihiko Koiwa, Masahide Mizobuchi, Shozo Koshikawa, Ikuji Hatamura, Hiroaki Ogata
Publikováno v:
Biochemical and Biophysical Research Communications. 362:11-16
Calcimimetic compounds inhibit not only parathyroid hormone (PTH) synthesis and secretion, but also parathyroid cell proliferation. The aim of this investigation is to examine the effect of the calcimimetic compound NPS R-568 (R-568) on parathyroid c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5050439deaf123eda1ef989f604467d0
https://doi.org/10.1016/j.bbrc.2007.07.177
https://doi.org/10.1016/j.bbrc.2007.07.177
Autor:
Masafumi, Fukagawa, Shigeru, Yumita, Tadao, Akizawa, Eiji, Uchida, Yusuke, Tsukamoto, Manabu, Iwasaki, Shozo, Koshikawa, Kazunori, Sonda
Publikováno v:
Nephrology Dialysis Transplantation. 23:328-335
Cinacalcet hydrochloride (KRN1493) acts on the parathyroid calcium receptors to suppress parathyroid hormone (PTH) secretion, and is already in wide use in the United States and the European countries. In this study, we examined the efficacy and safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cccac5cd07d56f47eb7bc2a8358d0932
https://doi.org/10.1093/ndt/gfm534
https://doi.org/10.1093/ndt/gfm534
Publikováno v:
Therapeutic Apheresis and Dialysis. 11:220-226
Darbepoetin alfa (KRN321) is a novel molecule that stimulates erythropoiesis by the same mechanism as endogenous erythropoietin. Due to its three-fold longer half-life and greater biological activity than recombinant human erythropoietin (rHuEPO), KR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da544fcaf009216fe818808c572ddcd1
https://doi.org/10.1111/j.1744-9987.2007.00474.x
https://doi.org/10.1111/j.1744-9987.2007.00474.x
Autor:
Eiji Uchida, Tadao Akizawa, Shozo Koshikawa, Hideji Tanaka, Hirotaka Takama, Hiroyasu Ogata, Daisuke Nakashima
Publikováno v:
British Journal of Clinical Pharmacology. 63:300-309
Aims To characterize the pharmacokinetics of darbepoetin alfa and covariate relationships in haemodialysis (HD) and peritoneal dialysis (PD) patients. Methods Data were collected from 131 (63 HD and 68 PD) patients who received darbepoetin alfa intra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64e2fd261e324b98135efda32790e215
https://doi.org/10.1111/j.1365-2125.2006.02756.x
https://doi.org/10.1111/j.1365-2125.2006.02756.x
Autor:
Shozo, Koshikawa
Publikováno v:
Nihon Jinzo Gakkai shi. 57(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9428a58251263120ed2a91dceaa97d7a
https://pubmed.ncbi.nlm.nih.gov/25735079
https://pubmed.ncbi.nlm.nih.gov/25735079
Autor:
Keizo Koide, Shunichi Fukuhara, Yasushi Asano, Tadao Akizawa, Kiyoshi Kurokawa, Shozo Koshikawa, Satoshi Morita
Publikováno v:
Therapeutic Apheresis and Dialysis. 10:72-77
We aimed to investigate prognostic factors for a composite end-point of end-stage renal disease (ESRD) and the progression of renal disease in Japanese patients with chronic renal disease. Using a composite end-point comprising a doubling of serum cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ab6bb3fbbe16302b68414dad8b653f7
https://doi.org/10.1111/j.1744-9987.2006.00307.x
https://doi.org/10.1111/j.1744-9987.2006.00307.x
Autor:
Hiroaki Ogata, Masahide Mizobuchi, Shozo Koshikawa, Kazuhiro Shiizaki, Fumihiko Koiwa, Shigeo Negi, Eriko Kinugasa, Tadao Akizawa, Ikuji Hatamura, Fumie Saji, Akira Ooshima
Publikováno v:
Nephrology Dialysis Transplantation. 21:911-916
Background. Cardiovascular disease is the most frequent cause of death in patients with end-stage kidney disease (ESKD). Vascular calcification is a confirmed risk factor for cardiovascular events in the general population and has a high occurrence i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89806041c5dea4984d38fa84550a3245
https://doi.org/10.1093/ndt/gfk008
https://doi.org/10.1093/ndt/gfk008
Autor:
Tadao Akizawa, Masahide Mizobuchi, Shozo Koshikawa, Susumu Uda, Shigeo Negi, Fumie Saji, Kazuhiro Shiizaki, Hiroaki Ogata, Ikuji Hatamura, Eriko Kinugasa, Toshifumi Sakaguchi
Publikováno v:
Journal of the American Society of Nephrology. 15:2579-2587
The reduced expression level of the calcium-sensing receptor (CaR) is attributed to the hyposensitivity of parathyroid cells to extracellular calcium concentration [Ca2+]o, which plays a crucial role in the pathogenesis of secondary hyperparathyroidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fe7cf81e8abfd7c71afd36e5f73de25
https://doi.org/10.1097/01.asn.0000141016.20133.33
https://doi.org/10.1097/01.asn.0000141016.20133.33
Autor:
Toshio Shinoda, Masahiko Nakamoto, Takao Shoji, Terukuni Ideura, Hiroshi Ogawa, Seiji Ohira, Tadao Akizawa, Masashi Suzuki, Kazuhiro Uchida, Yasushi Asano, Jun Minakuchi, Takashi Akiba, Noritomo Itami, Yoshiaki Takemoto, Eriko Kinugasa, Akira Saito, Shozo Koshikawa, Hidemune Naito, Yoshindo Kawaguchi
Publikováno v:
Nihon Toseki Igakkai Zasshi. 36:1709-1718
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aace790f6335626770ec3b661aa0e8f6
https://doi.org/10.4009/jsdt.36.1709
https://doi.org/10.4009/jsdt.36.1709